socaltech | Shared With: Everyone - Aug 08 2006 | cabrellis, cancer, lung, domain, associates, venture, capital, vc, investment, funding, anthracycline, socaltechSan Diego-based Cabrellis Pharmaceuticals, which is developing treatments for cancer, said Monday that it has raised $27.5M in a Series A funding round. Funding came from Domain Associates, Forward Ventures, Lilly Ventures, Novo A/S, ProQuest Investments,
Related Content from Around Faves
domains
-
Are you looking for top quality premium domains suitable and capable of branding your business websites and offline entities? NameClap.com offers many premimum domains on the web relevant to your business.
6 Favers - mike - 10 days ago3 FaversViewed: 6 Times
- AmmInfo - 16 days ago1 Faver
investment
-
This is not too surprising given Japan's dependency on U.S. consumers.
Let's see how this affects the U.S. markets tomorrow.
1 FaverViewed: 3 TimesQuoted: Japan’s economy has been hurt by weak export growth and steep cuts in corporate spending amid the worsening global slowdown.
- ClaraSet - 17 hours ago7 Favers
- ClaraSet - 21 hours ago3 Favers
